NetworkNewsBreaks – CytoDyn Inc. (CYDY) Interim CMO to Present at 11th Annual Conference on Stem Cell and Regenerative Medicine

CytoDyn Inc. (OTCQB: CYDY), a biotechnology company developing innovative treatments for multiple therapeutic indications, this morning announced that Richard G. Pestell, M.D., Ph.D., president of the Pennsylvania Cancer and Regenerative Medicine Research Center, distinguished professor at the Baruch S. Blumberg Institute and interim chief medical officer of CytoDyn, will deliver the keynote plenary speech at the 11th Annual Conference on Stem Cell and Regenerative Medicine in Helsinki, Finland. Pestell’s presentation, titled ‘Cancer stem cells, genetic drivers and therapeutic targeting via CCR5’, is scheduled to take place on Monday, October 15, from 10-11 am EEST. Pestell will present recent scientific evidence demonstrating the effectiveness of PRO 140 (leronlimab), which is shown to bind to CCR5 in human breast cancer, block CCR5 signaling induced by cytokines and block human breast cancer cell invasion.

To view the full press release, visit http://nnw.fm/SgzM0

About CytoDyn

CytoDyn is a biotechnology company developing innovative treatments for multiple therapeutic indications based on PRO 140 (leronlimab), a novel humanized monoclonal antibody targeting the CCR5 receptor. CCR5 plays a key role in the ability of HIV to enter and infect healthy T-cells.  The CCR5 receptor is also implicated in tumor metastasis and in immune-mediated illnesses such as graft-vs-host disease (GvHD) and NASH. CytoDyn has successfully completed a Phase 3 pivotal trial with PRO 140 in combination with standard anti-retroviral therapies in HIV-infected treatment-experienced patients. The Company plans to seek FDA approval for PRO 140 in combination therapy and plans to complete the filing of a Biological License Application (BLA) in the first quarter of 2019 for that indication. CytoDyn is also conducting a Phase 3 investigative trial with PRO 140 as a once-weekly monotherapy for HIV-infected patients, and plans to initiate a registration-directed study of PRO 140 monotherapy indication, which if successful, could support a label extension. Clinical results to date from multiple trials have shown that PRO 140 can significantly reduce viral burden in people infected with HIV with no reported drug-related serious adverse events (SAEs). Moreover, results from a Phase 2b clinical trial demonstrated that PRO 140 monotherapy can prevent viral escape in HIV-infected patients, with some patients on PRO 140 monotherapy remaining virally suppressed for more than four years. CytoDyn is also conducting a Phase 2 trial to evaluate PRO 140 for the prevention of GvHD and expects to initiate clinical trials with PRO 140 in metastatic triple-negative breast cancer in 2018. For more information, visit the company’s website at www.CytoDyn.com

More from NetworkNewsBreaks

NetworkNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Investee Adds Taxation Reporting Technology to its Proprietary Compliance Platform NetworkNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) Announces Results of Independent Studies Supporting Restart of Canadian Refinery NetworkNewsBreaks – The Flowr Corporation (TSX.V: FLWR) Ships Initial Purchase Order from the NSLC

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire has received compensation from CytoDyn Inc. for providing certain investor relations, marketing and social media services, including the preparation of this report, and expects to receive additional compensation for such services in the future. This compensation includes a monthly program fee.

More News From Lifestyle - In The Headline

Woman who fell to her death at the Grand Canyon identified

Apr 25, 2019

GRAND CANYON NATIONAL PARK, Ariz. — Authorities have identified an Arizona woman who died after falling over the edge of the South Rim at Grand Canyon National Park. Park officials say 69-year-old Cynthia Ackley fell about 200 feet (61 meters) Tuesday afternoon. She lived in the Phoenix suburb of Peoria. It was the second over-the-edge death this month within the confines of the national park. Park rangers got a call around 1 p.m. Tuesday about a visitor who needed help west of a popular overlook called Pipe Creek Vista. But authorities say Ackley fell before rescuers could get to the...

IndyCar hoping debris deflector helps protect drivers

Apr 25, 2019

INDIANAPOLIS — Will Power got his first real glimpse at IndyCar's new debris deflector Wednesday. He is still getting used to the small piece on the front of his race car. The defending Indianapolis 500 champion and 2014 series champion was one of more than two dozen drivers who spent Wednesday testing the safety device designed to reduce the risk of head injuries in the series that features open cockpits. "You notice it," the Australian driver said during a rain delay at Indianapolis Motor Speedway. "But you really need to be in it at top speeds, following cars. Anything you...

Poll: Americans split on college admissions fairness

Apr 25, 2019

BOSTON — As a sweeping bribery scandal reignites debate over college admissions, a pair of polls reveal that many Americans think the nation's universities place too much emphasis on factors such as wealth, family ties and athletic ability. The surveys , conducted by The Associated Press-NORC Center for Public Affairs Research and the Higher Education Analytics Center at NORC, finds Americans about evenly divided on the overall fairness of college admissions, but their views on individual selection criteria reveal a rift between the factors they see as important and the factors they think colleges value. The polls were conducted in...

UN: No screen time for babies; only 1 hour for kids under 5

Apr 25, 2019

LONDON — The World Health Organization has issued its first-ever guidance for how much screen time children under 5 should get: not very much, and none at all for those under 1. The U.N. health agency said Wednesday that kids under 5 should not spend more than one hour watching screens every day — and that less is better. The guidelines are somewhat similar to advice from the American Academy of Pediatrics. That group recommends children younger than 18 months should avoid screens other than video chats. It says parents of young children under two should choose "high-quality programming" with...

Jeweler, Sarah Jessica Parker settle breach-of-contract suit

Apr 25, 2019

NEW YORK — Sarah Jessica Parker and a British jeweler have settled a breach-of-contract lawsuit against the actress. Kat Florence Design sued Parker, arguing that she had agreed to promote a collaborative jewelry line of diamonds and other gems for a fee of $7.5 million but failed to live up to the obligation. Parker filed a lawsuit of her own, saying payments from the designer were "abruptly and without notice or explanation stopped" in October 2016. She said she was paid about $1.3 million. Details of the settlement in New York were not disclosed. "Kat Florence Design and Sarah Jessica...

Sign up now!

About Us

In The Headline sought to bring professionalism back into journalism, bringing you only the most exclusive and the most impactive news from all over the globe.

Contact us: sales[at]intheheadline.com